Maybe I am wrong, but I think that Fiona Stanley has a reputation to protect.
If they undertake a publicly registered trial, they are not going to be " actively pushing with patients". What would they gain from that?
Maybe they simply didn't find enough patients that qualified for the trial criteria, within the expected, cost based, time frame.
Sure, they may still be using the product, but on an informal, ad hoc, case-by-case basis, without the additional costs of audited reporting on a predetermined, publicly listed, set of criteria.
This is all purely, IMO, and highly speculative.
RCE Price at posting:
70.0¢ Sentiment: Hold Disclosure: Held
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)